Zobrazeno 1 - 10
of 111
pro vyhledávání: '"B. Maget"'
Autor:
B. Maget, N. Louvier, L. Lalourcey, M. Queinnec, D. Monnin, B. Ancel, D. Dupoiron, O. Brenet, H. Rosay, Christian Jayr, J.-M. Malinovsky, P. Mavoungou
Publikováno v:
Acta Anaesthesiologica Scandinavica. 57:106-111
Background An increasing number of immediate hypersensitivity reactions (HSR) have been reported after the use of Patent Blue V (PBV) for breast cancer surgery. This is the first study to publish prospective data with systematic allergological assess
Autor:
M. Pressoir, F Serot, J P Gekiere, B Maget, S Desné, Jocelyne Meuric, S Traversier, Marie-Paule Vasson, M Vittot, F Chelle, M.-N. Falewee, Pierre Senesse, D Berchery, M. Simon, I Rodrigues, M Meslier, Patrick Bachmann, B. Poirée, S Antoun, G. Rossignol
Publikováno v:
British Journal of Cancer
Background: This epidemiological observational study aimed at determining the prevalence of malnutrition in non-selected adults with cancer, to identify risk factors of malnutrition and correlate the results with length of stay and 2-month mortality.
Autor:
O, Brenet, L, Lalourcey, M, Queinnec, D, Dupoiron, C, Jayr, H, Rosay, P, Mavoungou, D, Monnin, B, Ancel, B, Maget, N, Louvier, J-M, Malinovsky
Publikováno v:
Acta anaesthesiologica Scandinavica. 57(1)
An increasing number of immediate hypersensitivity reactions (HSR) have been reported after the use of Patent Blue V (PBV) for breast cancer surgery. This is the first study to publish prospective data with systematic allergological assessment.We con
Publikováno v:
The Journal of Immunology. 149:2406-2414
Human CTL have been isolated that show self-restricted recognition of autologous lymphoblastoid cell lines and allorecognition. The lymphoblastoid cell line ligand most likely used a peptide that is expressed in EBV-bearing cells when the virus enter
Autor:
Dolores J. Schendel, S. Cayeux, B Maget, Heike Pohla, T. Blankenstein, Gerald Willimsky, E Nöbetaner, Petra Jantzer, Bernhard Frankenberger
Publikováno v:
Gene therapy. 7(23)
We have selected a well-characterized human renal cell carcinoma (RCC) line as the basis for development of a genetically engineered tumor cell vaccine to be applied in an allogeneic setting. This cell line was genetically modified by retroviral tran
Autor:
Dolores J. Schendel, Robert Tampé, E Nössner, Bernd Gansbacher, B Maget, S Urlinger, S Kressenstein, Christine S. Falk
Publikováno v:
Gene therapy. 7(11)
Even though renal cell carcinomas (RCC) are thought to be immunogenic, many tumors express variations in surface molecules and intracellular proteins that hinder induction of optimal antitumor responses. Interferon gamma (IFNgamma) stimulation can co
Autor:
Gert Riethmüller, E Nössner, Ralph Oberneder, S Kressenstein, Christine S. Falk, B Maget, Alfons Hofstetter, Petra Jantzer, Dolores J. Schendel
Publikováno v:
Journal of molecular medicine (Berlin, Germany). 75(6)
Renal cell carcinomas belong to the small group of tumors that are able to induce antitumor responses. Here we describe two general types of cytotoxic effector lymphocytes that can eliminate autologous tumor cells and discuss the role that major hist
Publikováno v:
Cellular Therapy ISBN: 9783662035115
The failure of metastatic renal cell carcinoma (RCC) to respond to irradiation, chemotherapy or hormone therapy has left immunotherapy as the most hopeful form of treatment to date. Systemic cytokine therapy of RCC using recombinant interleukin-2 (rI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e45132d75d0fcc0feffdae397bbfbc25
https://doi.org/10.1007/978-3-662-03509-2_5
https://doi.org/10.1007/978-3-662-03509-2_5
Publikováno v:
Immunology Methods Manual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdc8737303e1a7c0b4d152ea248d9ec7
https://doi.org/10.1016/b978-012442710-5/50070-8
https://doi.org/10.1016/b978-012442710-5/50070-8
Publikováno v:
Transfusion Clinique et Biologique. 17:393